Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) (COMRADE-B)
This study is currently recruiting participants.
Verified January 2013 by Novartis
Study NCT01396057
Information provided by Novartis
First Received on July 14, 2011.
Last Updated on January 15, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
